Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 280 No 7496 p387
5 April 2008

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Vascular checks could be done through pharmacies

Eliza Snow/iStockphoto

Blood pressure checks

BP checks will form part of assessment

What screening will involve

Under the proposals, all 40- to 74-year olds in England would be offered screening for vascular disease, which includes stroke, heart and kidney diseases and diabetes.

The initiative, which will cost the NHS £250m annually and will begin next year, could save around 2,000 lives and prevent 9,500 strokes or heart attacks, according to the DoH.

The screening will involve a patient health questionnaire as well as a blood pressure check and blood test for cholesterol.

Patients will receive a personal report detailing what steps they should take to minimise their risk of vascular disease.

Community pharmacy could play a leading role in delivering the Government’s national vascular screening programme for England, unveiled this week by health secretary Alan Johnson.

The Pharmaceutical Services Negotiating Committee confirmed, following the announcement, that it had identified vascular screening as a possible enhanced service under the pharmacy contract two years ago. A draft service specification has been with the Department of Health since last year.

Although the DoH refused to say whether community pharmacists would be paid for the work under the new contract, the PSNC said it was confident that it would be given enhanced service status.

The PSNC’s head of NHS services, Alastair Buxton, said: “The direction of travel from the department means it is more likely to be an enhanced service [than a national service].” He explained that it could be classified as a directed enhanced service.

“[This] means the department will tell primary care trusts to commission the service but does not mean it will direct a PCT where it has to commission the services from.”

Associate chief medical officer Bill Kirkup said: “We aim to make vascular disease checks available in a variety of convenient places. This could include GP surgeries, pharmacies or other community settings.”

Sue Sharpe, PSNC chief executive, said: “We can use the network of pharmacies and their easy accessibility to provide this support to people in locations at times that are convenient to them.”

The National Pharmacy Association pointed out that a national pharmacy service would provide the NHS with guaranteed coverage across all primary care trust areas. NPA chief pharmacist Colette McCreedy commented: “The access that pharmacy provides to the whole population, rather than just those that are ill, is a real asset the NHS can capitalise on, as it transforms into a service focused on health rather than illness.”

She added that the NPA would be providing support to pharmacists to deliver screening services as part of the organisation’s 2008 Ask Your Pharmacist campaign.

John D’Arcy, Numark interim managing director, welcomed the announcement. However, he warned that PCTs need to make greater strides in commissioning pharmacy services at a local level.

“We hope to see some kind of framework about this in the forthcoming White Paper. Pharmacy is ready, willing and able to do this — it is exactly what the contract is about.”

Family doctors, in contrast, said they were too hard pressed to take on the extra work. Chairman of the BMA’s General Practitioners Committee Laurence Buckman said: “We have serious concerns about the pressure this will put on an already overstretched general practice.”

Back to Top


©The Pharmaceutical Journal